MMCAP International’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

MMCAP International’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-277,303	Closed	-$1.12M	–	206
2023 Q4	$1.12M	Buy	+277,303	New	+$846K	0.21%	33

MMCAP International's THRX Position: Q1 2024 in Review

MMCAP International sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 277,303 shares — an estimated $1.12M sold.

MMCAP International first reported a position in THRX in Q4 2023 and held it in 1 quarter. The position peaked at $1.12M in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

MMCAP International reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
MMCAP International sold 277,303 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $1.12M.
MMCAP International first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
MMCAP International's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $1.12M in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on MMCAP International's 13F filing for Q1 2024, filed 9 May 2024.